News
Neuralink shouldn’t solve Anxiety and Depression disorders
Neuralink aims to treat some of the most severe and damaging neurological diseases on Earth. In terms of Alzheimer’s, dementia, and epilepsy, a Neuralink device would be a great way to prevent these diseases from ruining everyday life for those who have been affected by them. With that being said, Neuralink needs not to treat anxiety and depression disorders, because those illnesses require human reaction and vulnerability to treat. Defeating anxiety and depression should be done without the help of a complete fix, and it is crucial not to look past the importance of humans being able to feel these two sensations.
This is something I feel very strongly about for several reasons.
Before I dive into those reasons, I want to explain why I feel qualified enough to take a stance that I think many supporters of Neuralink will disagree with.
I have dealt with clinical anxiety and severe depression for my entire life. I was clinically diagnosed in 2009 at the age of 14 with both of these disorders, and I would estimate that it took me around 11 and a half years of diligence on my part to begin living a normal life. My anxiety and depression disorders hindered me from doing a lot of things in my life: playing certain sports, moving away for college (on multiple occasions), keeping past jobs, committing to relationships, etc. It has affected me in the worst way for so many years, and I would never want anyone, even my worst enemy, to experience the things that I felt on a daily basis when I was under the control of these two diseases.
However, I don’t think that everyone should completely rid themselves of anxiety and depression. Why? Because they are two emotions, as humans, we need to have.
Anxiety, while painful and difficult to confront head-on, is necessary for some reasons. The first being the obvious, anxiety is an excellent way to sense when danger is near, and it is a crucial part of our fight or flight response. It can warn someone when there is an issue with what is going on near them and can be life-saving in certain circumstances.
Anxiety also is an opportunity to grow as a human being. Facing and confronting anxious thoughts is one of the best ways to test resilience and learn about what we are made of. Anxiety teaches us a lot about ourselves, and while frightening, facing it directly is one of the best ways to show that we can push through certain circumstances that we aren’t confident about.
This is a preview from our weekly newsletter. Each week I go ‘Beyond the News’ and handcraft a special edition that includes my thoughts on the biggest stories, why it matters, and how it could impact the future.
A big thanks to our long-time supporters and new subscribers! Thank you.
Depression, while more severe in my own experiences, also has its advantages. Without darkness, we wouldn’t know what light is. Without depression, we wouldn’t know about happiness. There are points where humans need to face adversity and challenging circumstances to feel the great things about life.
Now, the way I treated my anxiety and depression disorders was a clinically-focused approach. I regularly attended therapy sessions, took medication, and spoke to doctors as often as I could. While I wholeheartedly believe everyone should talk to a therapist at least three times a year, I disagree with taking medications. In my experience, they are a masking agent for anxiety and depression disorders, especially. They caused me more problems after I started taking them, and the side effects needed treatment on their own.
I believe the best way to treat disorders like anxiety and depression is solely up to the person who is dealing with them. When I started to make real progress with my issues, I began using Exposure Therapy to treat my problems. I did as many things as I could that scared me. This included long drives by myself, roller coasters, and doing more things independently. When I started doing these things, I had stopped taking medication, and my self-diligence started to solve the problems I was facing.
I am in no way condoning that medication is not a wrong way to initially treat these illnesses. However, I do not believe that the healthy dose of side effects that come as a result of taking these medications is helpful to anyone who is being treated for either disorder.
This is where my issue with Neuralink comes in.
I believe that Neuralink intends to completely remove these sensations from a person’s emotions, which I feel can be dangerous to the future. Taking away emotions from humans can be detrimental to the way people communicate with each other and respond to specific events. As hazardous and as stressful as dealing with any mental illness is, solving them requires a long and tiring fight. It is not easy, but anything in life that is worth doing rarely is.
I believe very strongly that removing emotions from humans is one of the most dangerous things that anyone could do. At what point will devices like Neuralink completely take over the human brain? When will emotions begin to disappear from people? Could it lead to a decreased amount of social interaction? How would that make us any different than robots?
It is dangerous, in my opinion, to remove core emotional responses from a human. Nobody wants to be depressed, and nobody wants to be anxious. But treating these diseases is done by finding out who we are as people. It requires us to go out of our comfort zones and grow, not put a chip in our heads or a pill in our throats that eliminates the possibility of feeling certain sensations.
There comes the point where our humanness needs to be preserved. The invention of Smartphones has taken away a lot of opportunities for face-to-face interaction, and there is plenty of evidence to suggest that anxiety and depression disorders are caused by these devices, especially through social media use.
I am interested to hear other points on this matter because I know some people have different experiences with anxiety and depression than me. One thing I’ve always loved is hearing other people’s stories about how their anxiety or depression changed their lives. It usually starts with a valley and turns into a peak. While this can differ from case to case, two people rarely have identical stories when talking about their experiences. They also, frequently, are different from one case to the next because of how we obtained anxiety or depression. Some get it through abuse, and some get it from other forms of trauma when their brain is developing.
Neuralink is yet another brilliant idea from Elon Musk. It will hopefully change the way certain neurological diseases are treated and can provide some insight into what causes these medical conditions. However, there has to be boundaries and taking emotions and psychological responses away, in my opinion, is not the right thing to do. To quote Dr. Martin Luther King Jr., “Darkness cannot drive out darkness; only light can do that.”
I use this newsletter to share my thoughts on what is going on in the Tesla world. If you want to talk to me directly, you can email me or reach me on Twitter. I don’t bite, be sure to reach out!
Elon Musk
Ford CEO Farley says Tesla is not who to look at for EV expertise
Interestingly, Farley has been one of the most hellbent CEOs in terms of a legacy automaker standpoint to push the EV effort. It did not go according to plan, as Ford took a $19.5 billion charge and retreated from its EV push in late 2025.
Ford CEO Jim Farley said in a recent podcast interview that Tesla is not who Americans should look at to beat Chinese carmakers.
The comments have sparked quite a bit of outrage from Tesla fans on X, the social media platform owned by Elon Musk.
Farley said that Chinese automakers are better examples of how to beat competitors. He said (via the Rapid Response Podcast):
“If you’re an American and you want us to beat the Chinese in the car business, you’re all going to want to pay attention, not necessarily to Tesla. Nothing against Tesla—they’ve been doing great—but they really don’t have an updated vehicle. The best in the business for us, cost-wise and competition-wise, supply chain, manufacturing expertise, and the I.P. in the vehicle, was really BYD. In this next cycle of EV customers in the U.S., they want pickups and utilities and all these different body styles. But they want them at $30,000, not $50,000. Like the first inning, they want them affordably.”
Despite Farley’s synopsis, it is worth mentioning that Tesla had the best-selling passenger vehicle in the world last year, and in China in March, as the Model Y continued its global dominance over other vehicles.
Musk responded to Farley’s comments by stating:
“This is before Supervised FSD is approved in China. Limiting factor is production output in Shanghai.”
This is before supervised FSD is approved in China. Limiting factor is production output in Shanghai.
— Elon Musk (@elonmusk) April 19, 2026
Interestingly, Farley has been one of the most hellbent CEOs in terms of a legacy automaker standpoint to push the EV effort. It did not go according to plan, as Ford took a $19.5 billion charge and retreated from its EV push in late 2025.
Ford cancels all-electric F-150 Lightning, announces $19.5 billion in charges
Instead, Ford is “doubling down on its affordable” EVs and said it would pivot from its previous plans.
Reaction from Tesla fans was pretty much how you would expect. Many said they have lost a lot of respect for Farley after his comments; others believe he is the last CEO anyone should be taking advice on EVs from.
Nevertheless, Farley’s plans are bold and brash; many consider Tesla the most ideal company to replicate EV efforts from. It will be interesting to see if Ford can rebound from this big adjustment, and hopefully, Farley’s plans to replicate efforts from BYD work out the way he hopes.
Elon Musk
SpaceX wins its first MARS contract but it comes with a catch
NASA awarded SpaceX a $175 million Mars rover contract while the White House proposes cutting the mission.
NASA just signed a $175.7 million contract with SpaceX to launch a Mars rover that the White House is simultaneously trying to defund. The contract, awarded on April 16, 2026, tasks SpaceX’s Falcon Heavy with launching the European Space Agency’s (ESA) Rosalind Franklin rover from Kennedy Space Center in Florida, no earlier than late 2028. It would mark the first time SpaceX has ever sent a payload to Mars.
Under NASA’s Rosalind Franklin Support and Augmentation project, known as ROSA, the agency is providing braking engines for the rover’s descent stage, radioisotope heater units that use decaying plutonium to keep the rover warm on the Martian surface, additional electronics, and a mass spectrometer instrument, as noted by SpaceNews.
Those nuclear heating units are the reason an American rocket was required at all. U.S. export controls on radioisotope technology mean any payload carrying them must launch on a domestic vehicle, which narrowed the field to SpaceX and United Launch Alliance. Falcon Heavy’s pricing made it the practical choice.
SpaceX is quietly becoming the U.S. Military’s only reliable rocket
Falcon Heavy debuted in February 2018 and has 11 launches to its record. The rocket has not flown since October 2024, when it sent NASA’s Europa Clipper toward Jupiter. The three-core design, built from modified Falcon 9 first stages, gives it the lift capacity needed for deep space planetary missions that a single Falcon 9 cannot reach.
The Rosalind Franklin rover has been sitting in storage in Europe for years. It was originally due to launch in 2022 as a joint mission with Russia, but Russia’s invasion of Ukraine ended that partnership, leaving the rover built but stranded without a launch vehicle or landing hardware. NASA stepped back in through a 2024 agreement with ESA to rescue the mission. The rover is designed to drill up to two meters below the Martian surface in search of evidence of past life, a science objective no previous mission has attempted at that depth.
The contradiction at the center of this story is hard to ignore. The White House’s fiscal year 2027 budget proposal included no funding for ROSA and did not mention the mission at all in the detailed congressional justification document released April 3.
Musk has long argued that reaching Mars is not optional. “We don’t want to be one of those single planet species, we want to be a multi-planet species.” Whether this particular mission survives Washington’s budget fight, the Falcon Heavy contract means SpaceX is now formally on record as the rocket that could get humanity’s next Mars science mission off the ground.
The timing of this contract carries extra weight given that SpaceX filed confidentially with the SEC in early April and is targeting an IPO roadshow in the week of June 8. It would be the largest public offering in history.
Tesla (NASDAQ: TSLA) is set to hold its Earnings Call for the first quarter of 2026 on Wednesday, and there are a lot of interesting things that are swirling around in terms of speculation from investors.
With the company’s executives, including CEO Elon Musk, answering a handful of questions that investors submit through the Say platform, fans want to know a lot of things about a lot of things.
These five questions come from Retail Investors, who are normal, everyday shareholders:
- When will we have the Optimus v3 reveal? When will Optimus production start, since we ended the Model S and Model X production earlier than mid-year? What’s the expected Optimus production rate exiting this year? What are the initial targeted skills?
- What milestones are you targeting for unsupervised FSD and Robotaxi expansion beyond Austin this year, and how will that drive recurring revenue?
- How will Hardware 3 cars reach Unsupervised Full Self-Driving?
- When do you expect Unsupervised Full Self-Driving to reach customer cars?
- When will Robotaxi expand past its current limited rollout?
Additionally, these are currently the three questions that are slated to be answered by Institutional Firms, which also answer a handful of questions during the call:
- Now that FSD has been approved in the Netherlands and is expected to launch across Europe this summer, can you discuss your Robotaxi strategy for the region?
- What enabled you to finish the AI5 tapeout early and were there any changes to the original vision? Last week, Elon said AI5 will go into Optimus and the Supercomputer, but one month ago said it would go into the Robotaxi. Has AI5 been dropped from the vehicle roadmap?
- Given the recent NHTSA incident filings, can you update us on the Robotaxi safety data? If safety validation remains the primary bottleneck, why not deploy thousands of vehicles to accelerate the removal of the safety driver?
The questions range through every current Tesla project, including FSD expansion and Optimus. However, many of the answers we will get will likely be repetitive answers we’ve heard in the past.
This is especially pertinent when the questions about when Unsupervised FSD will reach customer cars: we know Musk will say that it will happen this year. Is Tesla capable of that? Maybe. But a more transparent answer that is more revealing of a true timeline would be appreciated.
Hardware 3 owners are anxiously awaiting the arrival of FSD v14 Lite, which was promised to them last year for a release sometime this year.
The Earnings Call is set to take place on Wednesday at market close.
Ford CEO Farley says Tesla is not who to look at for EV expertise
SpaceX wins its first MARS contract but it comes with a catch
